Maravai LifeSciences Inc...

NASDAQ: MRVI · Real-Time Price · USD
2.62
0.02 (0.77%)
At close: Aug 15, 2025, 3:59 PM
2.62
0.19%
After-hours: Aug 15, 2025, 06:49 PM EDT

Maravai LifeSciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-69.84M -29.95M -26.14M -99.04M -7.58M -12.08M -105.96M -6.46M -11.94M -1.35M 87.43M 99.65M 156.72M 146.86M 126.24M 132.81M 134.34M 75.85M
Depreciation & Amortization
15.39M 14.91M 14.53M 14.79M 14.55M 13.75M 12.98M 13.1M 11.8M 10.91M 10.03M 9.91M 10.78M 7.38M 3.44M 7.08M 7.34M 6.89M
Stock-Based Compensation
6.79M 10.4M 10.54M 13.05M 13.76M 12.06M 9.34M 9.99M 9.27M 5.99M 6M 4.74M 4.31M 3.63M 2.23M 3.57M 2.38M 2.28M
Other Working Capital
-4.25M -4.41M -1.25M 142K -1.06M -25.66M 11.69M 4.87M 1.41M -10.45M -5.79M -9.06M -6.67M -9.17M -56.6M -41.24M -17.39M 29.89M
Other Non-Cash Items
36.26M -10.25M -3.25M 75.56M -5.53M -11.56M -675.7M -5.5M -5.73M 2.71M 4.63M -3.52M -9.26M -544K 13.1M -14.47M 420K -5.21M
Deferred Income Tax
n/a n/a -300K 311K n/a n/a 764.75M -5.53M -2.76M -1.52M 7.01M 9.23M 12.86M 13.22M 17.47M 11.23M 6.45M 11.76M
Change in Working Capital
1.14M 5.49M -10.01M 8.46M 2.24M -10.64M 2.38M 8.57M 18.55M 68.34M -15.76M -9.96M -11.13M -8.24M -104.31M -34.36M 14.9M -52.85M
Operating Cash Flow
-10.27M -9.39M -14.64M 13.14M 17.43M -8.47M 7.79M 14.17M 19.19M 85.07M 99.33M 110.06M 164.28M 162.3M 58.17M 105.86M 165.83M 38.72M
Capital Expenditures
-2.87M -5.24M -6.35M -8.59M -9.55M -5.67M -16.8M -15.83M -25.06M -7.87M -6.21M -6.47M -1.66M -2.75M -5.66M -1.41M -4.2M -3.58M
Cash Acquisitions
-362K -18.63M n/a n/a n/a n/a 74.91M n/a 109K -69.73M -133K 620K n/a -238.84M n/a 119.96M n/a 548K
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a 734K 918K -368K 3.37M 1.42M -71.02M 307K 793K 7.87M -12.17M 620K n/a n/a n/a 119.96M n/a 548K
Investing Cash Flow
-3.24M -23.13M -4.93M -8.96M -6.18M -4.24M -12.9M -15.52M -24.16M -69.73M -18.52M -5.85M -1.66M -241.58M -5.66M 118.55M -4.2M -3.03M
Debt Repayment
-1.55M -1.54M -229.54M -1.52M -1.51M -1.5M -1.5M -1.48M -1.43M -1.36M -1.36M -1.36M -1.36M -1.36M -918K -1.72M -1.72M -1.64M
Common Stock Repurchased
n/a n/a -602K -19K -28K -1.43M n/a n/a n/a -333K n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
13K 1.38M -4.81M 2.35M 1.76M 2.38M 2.32M 2.27M -41.71M -17.52M -64.76M -36.08M -42.05M -39.16M -48.46M -49.57M -32.4M -22.56M
Financial Cash Flow
-1.53M -4.9M -234.95M 809K 228K -560K 470K 783K -43.13M -19.21M -66.12M -37.44M -43.41M -40.52M -49M -51.5M -34.35M -24.2M
Net Cash Flow
-15.15M -37.35M -255.76M 4.99M 11.48M -13.27M -4.64M -571K -48.1M -3.87M 14.69M 66.77M 119.21M -119.8M 3.37M 173.19M 127.03M 11.49M
Free Cash Flow
-13.14M -14.63M -20.99M 4.54M 7.88M -14.13M -9.01M -1.66M -5.87M 77.21M 93.12M 103.59M 162.62M 159.56M 52.51M 104.45M 161.63M 35.13M